Mardi C. Dier
2019
In 2019, Mardi C. Dier earned a total compensation of $2.8M as Executive Vice President, Chief Financial and Business Officer at Portola Pharmaceuticals, a 11% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $212,706 |
|---|---|
| Option Awards | $1,542,030 |
| Salary | $525,200 |
| Stock Awards | $508,125 |
| Other | $8,400 |
| Total | $2,796,461 |
Dier received $1.5M in option awards, accounting for 55% of the total pay in 2019.
Dier also received $212.7K in non-equity incentive plan, $525.2K in salary, $508.1K in stock awards and $8.4K in other compensation.
Rankings
In 2019, Mardi C. Dier's compensation ranked 4,374th out of 13,971 executives tracked by ExecPay. In other words, Dier earned more than 68.7% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 4,374 out of 13,971 | 69th |
Division Manufacturing | 1,613 out of 5,701 | 72nd |
Major group Chemicals And Allied Products | 565 out of 2,200 | 74th |
Industry group Drugs | 476 out of 1,886 | 75th |
Industry Pharmaceutical Preparations | 360 out of 1,398 | 74th |
Pay ratio
| Mardi C. Dier's Pay | $2,796,461 |
|---|---|
| Median Employee's Pay | $291,408 |
| Pay Ratio | 10to 1 |
In 2019, the annual total compensation of Mardi C. Dier was $2,796,461.
The annual total compensation of the median employee at Portola Pharmaceuticals was $291,408.
The ratio of Mardi C. Dier's pay to the pay of median employee was therefore 10 to one.
Source: SEC filing on April 20, 2020.
Dier's colleagues
We found four more compensation records of executives who worked with Mardi C. Dier at Portola Pharmaceuticals in 2019.